Digital Biology & Genetics

How Health IT Advancements Make Genomic Medicine a Reality

A few years ago, using genetic sequencing to better target and treat rare and chronic diseases was largely out of reach for most healthcare organizations due to cost and technology limitations, according to a recent panel discussion at the Cleveland Medical Innovation Summit.But with new and more cost-effective technologies emerging every day, the world of

[ Read More ]

FDA announces new market pathway for genetic health risk tests

FDA Commissioner Scott Gottlieb announced today that the agency intends to make a major change to its regulatory process around direct-to-consumer genetic health risk (GHR) tests. Specifically, the agency is creating a framework that will allow companies to bypass premarket certification for individual tests once they submit to a one-time review of their processes, an

[ Read More ]